Who Are the Core Customers of Aveanna Healthcare Company?

Infants and children with congenital anomalies, respiratory dependence (ventilators, trachs), or neurological impairments drive demand for Aveanna core customers; PDN for pediatrics historically accounts for over 65% of revenue in prior years and remained the dominant revenue source through fiscal 2025.

High-acuity adults who need skilled nursing or therapy to avoid institutionalization and families coordinating long-term home care comprise secondary customer segments; these adult home care customers of Aveanna complement pediatric volumes and increased by mid-single digits in 2025.

Aveanna Healthcare customers are a mixed base: direct consumer families and institutional payers-primarily Medicaid programs and MCOs-serve as referral sources for Aveanna and account for the majority of collections; in 2025 Medicaid and MCO contracts remained the principal payers and partners Aveanna works with.

The most commercially important cohort is pediatric PDN and an expanding focus on dual-eligible Medicare – Medicaid patients; management cited targeting dual-eligible populations in the 2025-2026 cycle to reduce total cost of care and capture higher-margin care coordination opportunities-this aligns with rising referrals from hospitals and clinics referring patients to Aveanna.

Sun Belt states, plus California and Pennsylvania, lead in home health demand because of large Baby Boomer cohorts and Medicaid policies that support higher home-care rates; these states accounted for an estimated ~55% of national PDN and home health referrals in 2025.

Urban centers with constrained hospital capacity generate referrals for hospital-at-home and transitional care programs; hospitals and clinics referring patients to Aveanna drive higher utilization of short-term, high-acuity home services.

The Medical Solutions channel is a strategic strength: enteral nutrition and respiratory supplies bundle with private duty nursing (PDN), and nearly 40% of Aveanna's PDN patients required these supplies in 2025, creating recurring product revenue and higher per-patient lifetime value.

In 2025-2026, the fastest growth appears in the Home Health and Hospice segment across the Sun Belt as Baby Boomers age; hospital-at-home adoption in dense metro areas is also expanding referral sources for Aveanna and payers and partners Aveanna works with.

Aveanna adds enteral nutrition and adult geriatric home care to capture more of the home health customers Aveanna market without changing its pediatric care model; these services use the same scheduling, billing, and clinical documentation platforms so incremental margins improve. In 2025 Aveanna focused expansion on geographies with existing PDN (private duty nursing) density to limit integration risk.

AVEANNA maintains segmented ops: dedicated pediatric clinical teams, separate quality metrics, and focused training curricula; this prevents dilution of focus and preserves outcomes for special needs children served by Aveanna Healthcare. The firm reports concentration on the top 5 percent most complex patients to protect clinical excellence.

By cross-selling PDN, enteral nutrition, and adult home care, Aveanna increases customer depth and platform stickiness; families who use Aveanna Healthcare services often renew and expand services, raising average revenue per patient. Referral sources for Aveanna-hospitals and clinics referring patients to Aveanna plus payers and partners Aveanna-drive recurring demand.

The strongest growth lever was preferred-payer optimization: in 2025 Aveanna intentionally shed low-margin contracts to concentrate on high-acuity cases and preferred payer relationships, improving profitability and clinical focus. This strategy boosted mix toward higher-margin PDN and specialty services and helped position Aveanna as a comprehensive home care platform in 2026.